Sonata Capital Group Inc. continued to hold its position in shares of UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,950 shares of the healthcare conglomerate’s stock at the end of the second quarter. Sonata Capital Group Inc.’s holdings in UnitedHealth Group were worth $275,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of UNH. MCF Advisors LLC raised its position in UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares during the period. Evanson Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter worth approximately $201,000. Parametrica Management Ltd acquired a new stake in UnitedHealth Group during the second quarter worth approximately $201,000. Finally, Franklin Street Advisors Inc. NC acquired a new stake in UnitedHealth Group during the second quarter worth approximately $208,000. Institutional investors own 85.78% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded up 0.14% during trading on Friday, hitting $136.66. 2,568,703 shares of the company’s stock traded hands. The firm’s 50-day moving average price is $137.92 and its 200 day moving average price is $136.28. UnitedHealth Group Inc. has a 12-month low of $107.51 and a 12-month high of $144.48. The stock has a market cap of $130.15 billion, a P/E ratio of 21.39 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The firm had revenue of $46.50 billion for the quarter, compared to analyst estimates of $45.05 billion. Analysts anticipate that UnitedHealth Group Inc. will post $7.90 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were given a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a yield of 1.83%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 39.12%.
A number of equities research analysts have recently commented on UNH shares. Wedbush restated an “outperform” rating and set a $165.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 19th. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a research report on Friday, July 22nd. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Citigroup Inc. raised their target price on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research report on Wednesday, July 20th. Finally, Credit Suisse Group AG restated a “buy” rating and set a $148.00 target price on shares of UnitedHealth Group in a research report on Wednesday, June 29th. One analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $155.35.
In related news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.